Acelity acquires Crawford Healthcare

Acelity said today it inked a deal to acquire advanced wound care and dermatology company Crawford Healthcare for an undisclosed amount. San Antonio, Texas-based Acelity said that the acquisition of Crawford will expand its advanced wound dressing product portfolio and strengthen its position in the advanced wound care market worldwide. Crawford Healthcare produces the KerraMax Care line of wound dressings and the KerraFoam and KerraCel foam and antimicrobial gelling fiber advanced wound dressings, Acelity said. Acelity touted that the combination of both its and Crawford’s wound care portfolios will create “the world’s most expansive wound care portfolio.” “The rapid growth of the business has been possible due to our focused investment in innovative products which are clinically proven to improve patient outcomes. Becoming part of the world’s largest wound care company will provide us with the scale to optimize our potential within the US, the largest global market and the ability to further access and grow in other international markets with our best-in-class advanced wound care products,” Crawford Helathcare CEO Richard Anderson said in a press release. Acelity said it is also acquiring Crawford’s research & development and manufacturing operations in Cheshire, U.K., and that former CEO Anderson will stay on to lead the acquired division as it integrates into Acelity. “Crawford’s talented team, highly complementary l...
Source: Mass Device - Category: Medical Devices Authors: Tags: Mergers & Acquisitions Wound Care Acelity Source Type: news